Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

BACKGROUND: Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal cancer. METHODS: All serious adverse events that...

Полное описание

Библиографические подробности
Главные авторы:	Kerr, D, Dunn, J, Langman, M, Smith, J, Midgley, R, Stanley, A, Stokes, J, Julier, P, Iveson, C, Duvvuri, R, McConkey, C
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
по: Midgley, R, и др.
Опубликовано: (2010)

VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
по: Kerr, D, и др.
Опубликовано: (2008)

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
по: Midgley, R, и др.
Опубликовано: (2008)

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
по: Gray, R, и др.
Опубликовано: (2007)

Adjuvant therapy of colorectal cancer.
по: Midgley, R, и др.
Опубликовано: (2000)

ABC of colorectal cancer: adjuvant therapy.
по: Midgley, R, и др.
Опубликовано: (2000)

QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients.
по: Gray, R, и др.
Опубликовано: (2004)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
по: Kerr, D, и др.
Опубликовано: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
по: Kerr, D, и др.
Опубликовано: (2000)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
по: Midgley, R, и др.
Опубликовано: (2005)

QUASAR Collaborative Group: a randomised study of adjuvant chemotherapy (CT) vs observation in predominantly stage II colorectal cancer
по: Kerr, D, и др.
Опубликовано: (2004)

Rofecoxib Induced Purpura
по: Dogra Sunil, и др.
Опубликовано: (2004-01-01)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
по: Midgley, R, и др.
Опубликовано: (2005)

The NSAID roller coaster: more about rofecoxib.
по: Aronson, J
Опубликовано: (2006)

CAPECITABINE (CAPE) +/- BEVACIZUMAB (BEV) IN THE ADJUVANT TREATMENT OF COLORECTAL CANCER (CRC) FIRST AND FINAL TOXICITY RESULTS FROM THE INTERNATIONAL PHASE III QUASAR2 TRIAL
по: Midgley, R, и др.
Опубликовано: (2012)

Rofecoxib, Diclofenac e Indometacina aumentam o risco de doença cardiovascular
по: Filipa Almada Lobo
Опубликовано: (2006-11-01)

Simultaneous Determination of Rofecoxib and Tizanidine by HPTLC
по: Uttam D. Pawar, и др.
Опубликовано: (2009-01-01)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
по: McQuay Henry J, и др.
Опубликовано: (2004-07-01)

Rofecoxib-Induced Hepatotoxicity: A Forgotten Complication of the Coxibs
по: Brian Yan, и др.
Опубликовано: (2006-01-01)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
по: Edwards, J, и др.
Опубликовано: (2004)

Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
по: McQuay Henry J, и др.
Опубликовано: (2004-02-01)

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
по: Sacchi Ada, и др.
Опубликовано: (2010-02-01)

Adjuvant chemotherapy for colorectal cancer.
по: Kerr, D, и др.
Опубликовано: (1996)

Rofecoxib improves quality of life in patients with hip or knee osteoarthritis
по: R Theiler, и др.
Опубликовано: (2002-10-01)

Single dose oral rofecoxib for acute postoperative pain in adults.
по: Bulley, S, и др.
Опубликовано: (2009)

Single dose oral rofecoxib for acute postoperative pain in adults.
по: Bulley, S, и др.
Опубликовано: (2009)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
по: Barden, J, и др.
Опубликовано: (2002)

The effect of rofecoxib and diclofenac on blood picture in male patients
по: Mohammed Z.K. Al-Hayali
Опубликовано: (2008-12-01)

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
по: Boyd Kathleen A, и др.
Опубликовано: (2011-12-01)

Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
по: McQuay Henry J, и др.
Опубликовано: (2002-06-01)

Immunotherapy for colorectal cancer.
по: Midgley, R, и др.
Опубликовано: (2003)

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach
по: Rozires P. Leão, и др.
Опубликовано: (2020-08-01)

Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data
Опубликовано: (2004)

Colorectal cancer.
по: Nicum, S, и др.
Опубликовано: (2003)

Colorectal cancer
по: Nicum, S, и др.
Опубликовано: (2003)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
по: Midgley, R, и др.
Опубликовано: (2013)

Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice
по: Fran Norflus, и др.
Опубликовано: (2004-11-01)

Chemotherapy for colorectal cancer.
по: Nicum, S, и др.
Опубликовано: (2000)

Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion
по: Gábor B. Brenner, и др.
Опубликовано: (2020-02-01)

SKIN PERMEATION ENHANCEMENT EFFECTS OF ASCORBIC ACID AND TRIETHYL CITRATE ON ROFECOXIB
по: MALAY K. DAS, и др.
Опубликовано: (2008-01-01)